DR. DIEGO MASTRONARDI M.D. NPI 1104822626

NPI Details

DR. Diego Mastronardi, M.D. is a family medicine in Bowling Green, KY with 37 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Diego Mastronardi, M.D. NPI is 1104822626. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

201 PARK ST
BOWLING GREEN, KY
ZIP 42101-708
Phone: (270) 783-3330
Fax: (270) 936-6030

The NPI 1104822626 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Bacterial colony count, urine (HCPCS:87086)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Vitamin d-3 level (HCPCS:82306)
• Iron level (HCPCS:83540)
• Ferritin (blood protein) level (HCPCS:82728)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• X-ray of chest, 2 views (HCPCS:71046)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Coronavirus vaccine 13 (HCPCS:91312)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Uric acid level, blood (HCPCS:84550)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Screening mammography (HCPCS:77067)
• Screening 3d breast mammography (HCPCS:77063)
• Bacterial urine culture (HCPCS:87088)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Magnesium level (HCPCS:83735)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Ldl cholesterol level (HCPCS:83721)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Coronavirus vaccine 14 (HCPCS:91313)
• Amylase (enzyme) level (HCPCS:82150)
• Lipase (fat enzyme) level (HCPCS:83690)
• X-ray of paranasal sinus, minimum of 3 views (HCPCS:70220)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)

The enumeration date for this NPI number is 6/21/2005 and was last updated on 5/17/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.